Pharmaceutical Payments to Japanese Certificated Pediatric
Hematologist/Oncologists: a cross-sectional analysis of personal
payments from pharmaceutical companies between 2016 and 2019Eiji Kusumi, MD1†, Anju Murayama2,3,†,*, Sae Kamamoto2, Takahiro
Maruyama2, Makoto Yoshida2, Hiroaki Saito,
MD4, Toyoaki Sawano, MD5, Erika
Yamashita2, Tetsuya Tanimoto, MD6, Akihiko Ozaki, MD, PhD7
Affiliations: 1Navitas Clinic Shinjuku, Shinjuku-ku, Tokyo,
Japan; 2 Medical Governance Research Institute, Minato-ku, Tokyo, Japan;
3 Tohoku University School of Medicine, Sendai City, Miyagi, Japan;
4Department of Gastroenterology, Sendai Kosei Hospital, Sendai City,
Miyagi, Japan; 5Department of Surgery, Jyoban Hospital of Tokiwa
Foundation, Iwaki City, Fukushima, Japan; 6 Department of Internal
Medicine, Navitas Clinic, Tachikawa City, Tokyo, Japan; 7 Department of
Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City,
Fukushima, Japan
† Authors equally contributed to this study
*Corresponding author
Address correspondence to : Anju Murayama, Medical Governance
Research Institute, 2-12-13 Takanawa, Minato-ku, Tokyo, Japan,
[ange21tera@gmail.com],
81-3-6455-7401.
Running Head: Pharmaceutical Payments to Japanese Pediatric
Oncologists
Word Counts for Abstract: 97 words
Word Counts for Text: 745 words
figure/table Count: 2
Number of Supplementary File: 1
Reference Count: 8
Keywords: Industry payment, Physician payment, The Japanese
Society for Pediatric Hematology and Oncology, Pediatric
Hematologist/Oncologist, Japan